Drug binding to HERG channels: evidence for a ‘non‐aromatic’ binding site for fluvoxamine
Open Access
- 1 July 2003
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 139 (5) , 883-884
- https://doi.org/10.1038/sj.bjp.0705336
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channelsProceedings of the National Academy of Sciences, 2002
- Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel BlockJournal of Biological Chemistry, 2002
- Mapping the receptor site for ergtoxin, a specific blocker of ERG channelsFEBS Letters, 2001
- Open Channel Block of HERG K+ Channels by VesnarinoneMolecular Pharmacology, 2001
- Molecular and Cellular Mechanisms of Cardiac ArrhythmiasCell, 2001
- A structural basis for drug-induced long QT syndromeProceedings of the National Academy of Sciences, 2000
- Trapping of a Methanesulfonanilide by Closure of the Herg Potassium Channel Activation GateThe Journal of general physiology, 2000
- Molecular Determinant of High-Affinity Dofetilide Binding to HERG1 Expressed in Xenopus Oocytes: Involvement of S6 SitesMolecular Pharmacology, 2000
- Blocker protection in the pore of a voltage-gated K+ channel and its structural implicationsNature, 2000
- Use-dependent block and use-dependent unblock of the delayed rectifier K+ current by almokalant in rabbit ventricular myocytes.Circulation Research, 1993